scholarly journals Long-term protective immunity to rinderpest in cattle following a single vaccination with a recombinant vaccinia virus expressing the virus haemagglutinin protein

2000 ◽  
Vol 81 (6) ◽  
pp. 1439-1446 ◽  
Author(s):  
Kazue Ohishi ◽  
Kenjiro Inui ◽  
Kazuya Yamanouchi ◽  
Thomas Barrett
Vaccine ◽  
2007 ◽  
Vol 25 (7) ◽  
pp. 1334-1341 ◽  
Author(s):  
Shinya Fukumoto ◽  
Yoh Tamaki ◽  
Masashi Okamura ◽  
Hiroshi Bannai ◽  
Natsuko Yokoyama ◽  
...  

1997 ◽  
Vol 59 (3-4) ◽  
pp. 293-309 ◽  
Author(s):  
Zelia I.P. Lobato ◽  
Barbara E.H. Coupar ◽  
Christian P. Gray ◽  
Ross Lunt ◽  
Marion E. Andrew

1998 ◽  
Vol 72 (12) ◽  
pp. 9567-9574 ◽  
Author(s):  
Joseph E. Blaney ◽  
Eri Nobusawa ◽  
Michael A. Brehm ◽  
Robert H. Bonneau ◽  
Lawrence M. Mylin ◽  
...  

ABSTRACT We have evaluated the potential of conferring protective immunity to herpes simplex virus type 2 (HSV-2) by selectively inducing an HSV-specific CD8+ cytotoxic T-lymphocyte (CTL) response directed against a single major histocompatibility complex class I-restricted CTL recognition epitope. We generated a recombinant vaccinia virus (rVV-ES-gB498-505) which expresses the H-2Kb-restricted, HSV-1/2-cross-reactive CTL recognition epitope, HSV glycoprotein B residues 498 to 505 (SSIEFARL) (gB498-505), fused to the adenovirus type 5 E3/19K endoplasmic reticulum insertion sequence (ES). Mucosal immunization of C57BL/6 mice with this recombinant vaccinia virus induced both a primary CTL response in the draining lymph nodes and a splenic memory CTL response directed against HSV gB498-505. To determine the ability of the gB498-505-specific memory CTL response to provide protection from HSV infection, immunized mice were challenged with a lethal dose of HSV-2 strain 186 by the intranasal (i.n.) route. Development of the gB498-505-specific CTL response conferred resistance in 60 to 75% of mice challenged with a lethal dose of HSV-2 and significantly reduced the levels of infectious virus in the brains and trigeminal ganglia of challenged mice. Finally, i.n. immunization of C57BL/6 mice with either a recombinant influenza virus or a recombinant vaccinia virus expressing HSV gB498-505 without the ES was also demonstrated to induce an HSV-specific CTL response and provide protection from HSV infection. This finding confirms that the induction of an HSV-specific CTL response directed against a single epitope is sufficient for conferring protective immunity to HSV. Our findings support the role of CD8+ T cells in the control of HSV infection of the central nervous system and suggest the potential importance of eliciting HSV-specific mucosal CD8+ CTL in HSV vaccine design.


Sign in / Sign up

Export Citation Format

Share Document